ISSWSH Annual Meeting 2020

   March 5-8, 2020
   Renaissance Orlando at Seaworld
Orlando, FL, USA

Preliminary Scientific Program

Thursday, March 5, 2020
Morning
07:00 a.m. - 12:15 p.m.
Location: Peninsula 1-3
Annual Pre-Course (Separate Registration Required)
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
Is subsession
Child level: 1
07:00 a.m. - 07:30 a.m.
Location: Foyer
Breakfast - Pre-Course Registrants Only
07:30 a.m. - 07:40 a.m.
Location: Peninsula 1-3
Welcome and Introduction
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
07:40 a.m. - 09:10 a.m.
Location: Peninsula 1-3
Identification of Sexual Health Problems
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
07:40 a.m. - 08:00 a.m.
Update on Epidemiology and Nomenclature
Speaker: Sharon Parish, MD, IF, NCMP (USA)
08:00 a.m. - 08:25 a.m.
Sexual Health Interview
Speaker: Sharon Parish, MD, IF, NCMP (USA)
08:25 a.m. - 08:40 a.m.
Physical Exam
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
08:40 a.m. - 09:10 a.m.
Testing Procedures: Hormonal, Vascular, Neurologic
Speaker: Rachel Rubin, MD, IF (USA)
09:10 a.m. - 09:25 a.m.
Location: Foyer
Coffee Break
09:25 a.m. - 10:15 a.m.
Location: Peninsula 1-3
HSDD
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
09:25 a.m. - 09:50 a.m.
ISSWSH Processes of Care
Speaker: Sharon Parish, MD, IF, NCMP (USA)
09:50 a.m. - 10:15 a.m.
Non-Hormonal Pharmacological Treatments
Speaker: Rachel Rubin, MD, IF (USA)
10:15 a.m. - 10:55 a.m.
Location: Peninsula 1-3
Hormones
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
10:15 a.m. - 10:40 a.m.
Hormonal Treatment: Estrogens and Progestogens
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
10:40 a.m. - 10:55 a.m.
Hormonal Treatment: Androgens
Speaker: Sharon Parish, MD, IF, NCMP (USA)
10:55 a.m. - 11:50 a.m.
Location: Peninsula 1-3
Sexual Pain
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
10:55 a.m. - 11:15 a.m.
Painful Intercourse: Causes, Evaluation and Treatment
Speaker: Rachel Rubin, MD, IF (USA)
11:15 a.m. - 11:35 a.m.
Vestibulodynia: Diagnosis and Treatment
Speaker: Rachel Rubin, MD, IF (USA)
11:35 a.m. - 11:50 a.m.
Treatment Options for GSM
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
11:50 a.m. - 12:00 p.m.
Location: Peninsula 1-3
Q&A
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
12:00 p.m. - 12:15 p.m.
Location: Foyer
Lunch - Pre-Course Registrants Only
Afternoon
12:15 p.m. - 12:30 p.m.
Location: Peninsula 4
Opening Ceremony
Welcome Comments
Speaker: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA)
12:30 p.m. - 01:30 p.m.
Location: Peninsula 4
Sandra Leiblum ISSWSH Presidential Lecture
Moderator: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA)
How the US Government and The Media Conspired to Convince Women That Menopausal Hormone Therapy Was Dangerous
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
01:30 p.m. - 03:00 p.m.
Location: Peninsula 4
Symposium 1 - Caring for Transgender Patients: What Every Provider Needs to Know
Moderators: Heather Howard, PhD, MPH, MBA, AASECT-CSC, AASECT-CSE, IF (USA) & Tami Rowen, MD, MS, FACOG, IF (USA)
01:30 p.m. - 02:00 p.m.
Caring for the Whole Person: Addressing Social, Psychological, Relational, and Cultural issues for Gender Diverse Patients
Speaker: Laura Jacobs, LCSW-R (USA)
02:00 p.m. - 02:20 p.m.
Physical Therapy in Transgender Health Care
Speaker: Hollis Herman, DPT, OCS, WCS, BCB-PMD, AASECT, PRPC, IF (USA)
02:20 p.m. - 03:00 p.m.
Best Practices in Medical Treatment for Transgender Patients: Hormone Therapy, Pre- and Post-operative Care, Gender-confirming Surgeries, and Co-occurring Medical Concerns
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
03:00 p.m. - 03:30 p.m.
Location: Canaveral
Coffee Break
03:00 p.m. - 03:30 p.m.
Location: Foyer
New Member/New Attendee Meet-Up
03:30 p.m. - 04:30 p.m.
Location: Peninsula 4
State of the Art Session 1 - Lessons From the Sex Wars: Do Good Values Make Bad Sexual Science?
Moderators: Irwin Goldstein, MD, IF (USA) & James Simon, MD, CCD, NCMP, FACOG, IF (USA)
Speaker: William Fisher, PhD (Canada)
04:30 p.m. - 06:00 p.m.
Location: Peninsula 1-3
Instructional Course 1 - Vulvar Dermatoses
Speakers: Andrew Goldstein, MD, IF, FACOG (USA) & Lynette Margesson, MD (USA)
04:30 p.m. - 06:10 p.m.
Location: Peninsula 4
Research Podium Session 1 - Chronic Illness, Pain and New Technologies
Moderators: Joshua Gonzalez, MD (USA) & Paul Yong, MD, PhD, FRCSC (Canada)
04:30 p.m. - 04:40 p.m.
A Novel Collaboration for Successful Management of Genito-Pelvic Dysesthesias Mediated by Radiculopathy of Sacral Spinal Nerve Roots Within the Cauda Equina: Four-Year Experience (#001)
Speaker: Choll Kim, MD, PhD (USA)
04:40 p.m. - 04:50 p.m.
Sexual Dysfunction in Relation to Tumor Type, Location, and Treatment in Brain Cancer Patients (#002)
Speaker: Maria Boccia (USA)
04:50 p.m. - 05:00 p.m.
Sleeping Beauty Syndrome: A Rare Sleep Sexuality Disorder (#003)
Speaker: Blake Zwerling (USA)
05:00 p.m. - 05:10 p.m.
Safety and Efficacy of CO2 Fractional Laser Therapy in Women with Vestibulodynia (#004)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
05:10 p.m. - 05:20 p.m.
Clitorodynia: The Unexplored Subtype of Vulvodynia. Preliminary Results of a Cross-sectional Controlled Study (#005)
Speaker: Leen Aerts (Switzerland)
05:20 p.m. - 05:30 p.m.
Sexual Function in Women after Treatment for Colorectal Cancer and Anal Cancer (#006)
Speaker: Marissa Savoie (USA)
05:30 p.m. - 05:40 p.m.
The Bionic Breast Project: Developing a Measure of Breast Function in Women With and Without a History of Breast Cancer using PROMIS Standards (#007)
Speaker: Emily Abramsohn (USA)
05:40 p.m. - 05:50 p.m.
A Qualitative Exploration of Sexual Quality of Life, Medication Adherence, and Patient-provider Sexual Communication Among Black Breast Cancer Survivors with Sexual Trauma Histories (#008)
Speaker: Janeane Anderson (USA)
05:50 p.m. - 06:00 p.m.
Retrospective Chart Review of Treatment Outcome Following Low-Intensity Shockwave Therapy for the Treatment of Vestibulodynia with Urogold 100™ MTS (#009)
Speaker: Jessica Yih (USA)
06:00 p.m. - 06:10 p.m.
The Moderation Effect of Couple-level Sexual Satisfaction on Physiological Synchrony During Conversation-based Tasks (#010)
Speaker: Bridget Freihart (USA)
Evening
06:00 p.m. - 07:30 p.m.
Location: Canaveral
Welcome Reception
Friday, March 6, 2020
Morning
07:00 a.m. - 08:00 a.m.
Location: Peninsula 5-7
Industry Sponsored Breakfast Symposium
08:00 a.m. - 09:00 a.m.
Location: Peninsula 4
State of the Art Session 2 - A Reflection on Genital Self-image: Epidemiological and Surgical Perspectives of a Complex Issue
Moderators: Nicole Cirino, MD (USA) & Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA)
Speakers: Michael Goodman, MD, FACOG, NCMP, IF (USA) & Tami Rowen, MD, MS, FACOG, IF (USA)
09:00 a.m. - 10:30 a.m.
Location: Peninsula 1-3
Instructional Course 2 - Sensate Focus
Speakers: Constance Avery-Clark, PhD (USA) & Linda Weiner, MSW (USA)
09:00 a.m. - 10:40 a.m.
Location: Peninsula 4
Research Podium Session 2 - Clinical Trials in FSD
Moderators: Anita Clayton, MD, IF (USA) & Noel Kim, PhD, IF (USA)
09:00 a.m. - 09:10 a.m.
Correlation Between Validated Instruments Used in the RECONNECT Studies (#011)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
09:10 a.m. - 09:20 a.m.
Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With Hypoactive Sexual Desire Disorder (#012)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
09:20 a.m. - 09:30 a.m.
The Development and Implementation of a Gynecologic Cancer Survivorship Tool (#013)
Speaker: Jeanne Carter (USA)
09:30 a.m. - 09:40 a.m.
“I Don’t Want to Get Fat, and I Don’t Like Working Out So….” - Perceptions of Contraception Among College-aged Students: Weight Gain vs Protection (#014)
Speaker: Oluwabunmi Ogungbe (USA)
09:40 a.m. - 09:50 a.m.
The Impact of Incontinence Procedures at the Time of Vaginal Vault Suspension on Pelvic Pain and Dyspareunia: A Study of Sexually Active Women with Post Hysterectomy Prolapse (#015)
Speaker: Veronica Winget (USA)
09:50 a.m. - 10:00 a.m.
Effectiveness of Medications for Female Sexual Dysfunction: Number Needed To Treat (NNT) (#016)
Speaker: Robert Pyke (USA)
10:00 a.m. - 10:10 a.m.
Retrospective Review of Lumbo-Sacral Shockwave Therapy Outcomes for Genito-pelvic Dysesthesia/Persistent Genital Arousal Disorder (#017)
Speaker: Jessica Yih (USA)
10:10 a.m. - 10:20 a.m.
The Impact of Labia Minora Labiaplasty on Patients' Perceptions of Their Genitals (#018)
Speaker: Troy Hailparn (USA)
10:20 a.m. - 10:30 a.m.
Evaluating the Role of Relationship Status in the Sexual Well-being of Women With and Without Histories of Nonconsensual Sexual Experiences (#019)
Speaker: Mackenzie Sears (USA)
10:30 a.m. - 10:40 a.m.
Oral Contraceptive use Influences Subjective and Physiological Sexual Arousal (#020)
Speaker: Ariel Handy (USA)
10:30 a.m. - 11:00 a.m.
Location: Canaveral
Coffee Break
11:00 a.m. - 11:30 a.m.
Location: Peninsula 4
ISSM Lecture
Moderator: Luiz Otavio Torres, MD (Brazil)
Why Do We Have Sex?
Speaker: Annamaria Giraldi, MD, PhD, IF (Denmark)
11:30 a.m. - 12:00 p.m.
Location: Peninsula 4
ESSM Lecture
Moderator: Michal Lew-Starowicz, MD, PhD (Poland)
Pelvic Organ Disorders and Sexual Function
Speaker: Lior Lowenstein, MD, MS, MHA, MBA (Israel)
Afternoon
12:00 p.m. - 01:00 p.m.
Location: Peninsula 4
Lunch and Learn 1 - Alternative Sexual Practices: Polyamory and BDSM
Speakers: Brooke Faught, DNP, WHNP-BC, NCMP, IF (USA) & Susan Kellogg-Spadt, PhD, CRNP, IF (USA)
12:00 p.m. - 01:00 p.m.
Location: Peninsula 1-3
Lunch and Learn 2 - Sexual Health in Muslim, Southeast Asian and Arab Women
Speaker: Sameena Rahman, MD, IF (USA)
01:00 p.m. - 02:00 p.m.
Location: Peninsula 4
State of the Art Session 3 - PGAD: Where are we now?
Moderators: Sharon Parish, MD, IF, NCMP (USA) & Rachel Rubin, MD, IF (USA)
Speakers: Irwin Goldstein, MD, IF (USA) & Choll Kim, MD, PhD (USA)
02:00 p.m. - 02:30 p.m.
Location: Peninsula 4
SSTAR Lecture
Moderator: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA)
A Randomized Clinical Trial Comparing a Cognitive-behavioral Couple Intervention and Lidocaine for Women with Provoked Vestibulodynia
Speaker: Sophie Bergeron, PhD (Canada)
02:30 p.m. - 03:00 p.m.
Location: Peninsula 4
Scientific Network on Female Sexual Health and Cancer Lecture
Moderator: Sharon Parish, MD, IF, NCMP (USA)
Sexual Health in Special Cancer Populations
Speaker: Shari Goldfarb, MD (USA)
03:00 p.m. - 03:30 p.m.
Location: Canaveral
Coffee Break
03:30 p.m. - 05:00 p.m.
Location: Peninsula 4
Symposium 2 - Sex: A Body in the Mirror....
Moderator: Nicole Cirino, MD (USA)
03:30 p.m. - 04:00 p.m.
......Unraveling Cardio Metabolic Diseases
Speaker: Elisa Maseroli, MD (Italy)
04:00 p.m. - 04:30 p.m.
......Unravelling Orthopedic Diseases
Speaker: Karen Brandon, DSc, PT (USA)
04:30 p.m. - 05:00 p.m.
......Unraveling Neurological Diseases
Speaker: Mitchell Tepper, PhD, MPH (USA)
05:00 p.m. - 05:45 p.m.
Location: Peninsula 4
Journals Session
Moderator: Irwin Goldstein, MD, IF (USA)
05:00 p.m. - 05:15 p.m.
Journal of Sexual Medicine - Androgen Receptor Polymorphism and Female Sexual Function and Desire
Speaker: Annamaria Giraldi, MD, PhD, IF (Denmark)
05:15 p.m. - 05:30 p.m.
Sexual Medicine Reviews - The Role of Physical Therapy in Sexual Health in Men and Women: Evaluation and Treatment
Speaker: Amy Stein, DPT, BCB-PMD, IF (USA)
05:30 p.m. - 05:45 p.m.
Sexual Medicine - The Relationship between Marijuana Use Prior to Sex and Sexual Function in Women
Speaker: Becky K. Lynn, MD, IF (USA)
Evening
05:45 p.m. - 06:45 p.m.
Location: Peninsula 1-3
ISSWSH Business Meeting (members only)
06:45 p.m. - 07:45 p.m.
Location: Biscayne
Early Career Professionals Mixer (with drinks and food)
Saturday, March 7, 2020
Morning
06:30 a.m. - 08:00 a.m.
Location: Peninsula 4
Special Interest Breakfast - PGAD
07:00 a.m. - 08:00 a.m.
Location: Peninsula 1-3
Special Interest Breakfast - Management of Sexual Pain / Dyspareunia
07:00 a.m. - 07:05 a.m.
Introductions and Review of Progress of the ISSWSH SIG on Sexual Pain/Dyspareunia
07:05 a.m. - 07:30 a.m.
Dysorgasmia Case Presentations and Discussion
07:30 a.m. - 07:45 a.m.
Building a Framework for Diagnosis/Management of Dysorgasmia
07:45 a.m. - 08:00 a.m.
Preparing for a Review Article on Dysorgasmia
07:00 a.m. - 08:00 a.m.
Location: Peninsula 5-7
Special Interest Breakfast - Scientific Network on Female Sexual Health and Cancer
08:00 a.m. - 09:00 a.m.
Location: Peninsula 4
Staying Connected: Using Social Media as a Networking Tool to Enhance Patient Care
Moderator: Becky K. Lynn, MD, IF (USA)
Speakers: Dana Corriel, MD (USA) & Allan Gelbard, Esq. (USA)
09:00 a.m. - 10:30 a.m.
Location: Peninsula 4
Symposium 3 - HSDD
Moderators: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA) & Tami Rowen, MD, MS, FACOG, IF (USA)
09:00 a.m. - 09:22 a.m.
FSIAD, Sexual Desire and Arousal
Speaker: Meredith Chivers, PhD, CPsych (Canada)
09:22 a.m. - 09:44 a.m.
ISSWSH Clinical Practice Guideline on the Use of Systemic Testosterone Therapy for HSDD/FSD
Speaker: Sharon Parish, MD, IF, NCMP (USA)
09:44 a.m. - 10:06 a.m.
Basic Science Behind HSDD
Speaker: James Pfaus, PhD, IF (Canada)
10:06 a.m. - 10:28 a.m.
CNS and HSDD
Speaker: Brooke Faught, DNP, WHNP-BC, NCMP, IF (USA)
10:30 a.m. - 11:00 a.m.
Location: Canaveral
Coffee Break
11:00 a.m. - 12:00 p.m.
Location: Peninsula 4
State of the Art Session 4 - Survey on Sexual Fantasies
Moderators: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA) & Heather Howard, PhD, MPH, MBA, AASECT-CSC, AASECT-CSE, IF (USA)
Speaker: Justin Lehmiller, PhD (USA)
Afternoon
12:00 p.m. - 01:00 p.m.
Location: Peninsula 5-7
Special Lunch Symposium
01:00 p.m. - 02:30 p.m.
Location: Peninsula 1-3
Instructional Course 3 - Neurologic Causes of Sexual Dysfunction
Speakers: Irwin Goldstein, MD, IF (USA); Choll Kim, MD, PhD (USA) & Barry Komisaruk, PhD (USA)
01:00 p.m. - 02:40 p.m.
Location: Peninsula 4
Research Podium Session 3 - Basic and Translational Research
Moderator: Noel Kim, PhD, IF (USA)
01:00 p.m. - 01:10 p.m.
Brain Activity Generated by Self and Partner-Induced Orgasm: Functional MRI Evidence (#021)
Speaker: Nan Wise (USA)
01:10 p.m. - 01:20 p.m.
Preliminary Efficacy of Sildenafil Cream, 3.6% During Female Sexual Arousal (#022)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
01:20 p.m. - 01:30 p.m.
Investigation of Sensory Innervation in the Surgical Field of Mid-Urethral Sling and Loop Electrosurgical Excision Procedures in Periurethral and Cervical Tissues Using Immunohistochemistry (#023)
Speaker: Olivia Giovannetti (Canada)
01:30 p.m. - 01:40 p.m.
Estradiol/Progesterone Oral Capsules Improved Vaginal Dryness in Women with Vasomotor Symptoms (VMS) with No Negative Effects on Desire (#024)
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
01:40 p.m. - 01:50 p.m.
Effects of Systemic Treatment With Testosterone in Women With Sexual Dysfunction: An Observational Pilot Study (#025)
Speaker: Elisa Maseroli, MD (Italy)
01:50 p.m. - 02:00 p.m.
A Rapid, High-volume, See-and-treat Cervical Cancer Screening Program using Self-sampling, HPV PCR Testing, and Digital Colposcopy in Inner Mongolia (#026)
Speaker: Sarah Bedell (USA)
02:00 p.m. - 02:10 p.m.
Plasma Cell Mucositis of the Vagina and Cervix (#027)
Speaker: Leia Mitchell (USA)
02:10 p.m. - 02:20 p.m.
Impact of Vaginal Prasterone on the Frequency of Urinary Tract Infections (#028)
Speaker: Rachel Rubin, MD, IF (USA)
02:20 p.m. - 02:30 p.m.
Gender Intracrinology: The Vagina as an Androgen Target and Synthesis Organ (#029)
Speaker: Elisa Maseroli, MD (Italy)
02:30 p.m. - 02:40 p.m.
A Randomized, Active Placebo-controlled Trial of an Online Expressive Writing Intervention for the Sexual Well-being of Women with Childhood Sexual Abuse histories (#030)
Speaker: Chelsea Kilimnik (USA)
02:30 p.m. - 03:00 p.m.
Location: Canaveral
Coffee Break
03:00 p.m. - 03:30 p.m.
Location: Peninsula 4
NAMS Lecture
Moderator: Alyse Kelly-Jones, MD, IF, FACOG (USA)
Sex, Drugs and Rock And Roll
Speaker: Sheryl Kingsberg, PhD, IF (USA)
03:30 p.m. - 05:00 p.m.
Location: Peninsula 4
Symposium 4 - Hormonal Contraception: More Than You Bargained For?
Moderators: William Fisher, PhD (Canada) & Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
03:30 p.m. - 04:00 p.m.
Biologic Effects of Hormonal Contraceptives (ESSM Position Statement)
Speaker: Linda Vignozzi, MD (Italy)
04:00 p.m. - 04:30 p.m.
Psychosexual Effects of Hormonal Contraceptives (ESSM Position Statement)
Speaker: Michal Lew-Starowicz, MD, PhD (Poland)
04:30 p.m. - 05:00 p.m.
Risk Behaviors Related to Contraception
Speaker: William Fisher, PhD (Canada)
05:00 p.m. - 05:30 p.m.
Location: Peninsula 4
IUGA Lecture
Moderator: Juliana Kling, MD, MPH, NCMP, FACP (USA)
Sexual Function after Pelvic Floor Surgery: Pitfalls and Pearls
Speaker: Sylvia Botros-Brey, MD (USA)
Evening
05:30 p.m. - 07:00 p.m.
Location: Biscayne
Poster Session (with drinks and food)
Knowledge and Perception of Sexual Health Among Saudi Population (#040)
Speaker: Hasan Alkhudairi (Saudi Arabia)
Preliminary Report of a Novel Therapy for Chronic Pelvic Pain: SoLá Therapy (#041)
Speaker: Charles Butrick (USA)
Breast Cancer Patients in a Female Sexual Medicine and Women’s Health Program: A Cross-sectional Retrospective Study (#042)
Speaker: Jeanne Carter (USA)
Different Forms of Mental Health Treatments are Associated with Different Patterns of Posttrauma Sexual Functioning in Women: An Exploratory Study (#043)
Speaker: Kirstin Clephane (USA)
Sexual and Emotional Affairs: Does Friendship Matter? (#044)
Speaker: Courtney Crosby (USA)
Sexual Disgust and Sexual Satisfaction (#045)
Speaker: Courtney Crosby (USA)
Feasibility, Acceptability and Effects of Physical Therapy Treatment for Gynecological Cancer Survivors with Dyspareunia (#046)
Speaker: Marie-Pierre Cyr (Canada)
Sexual Health and Cancer: An Awkward Silence (#047)
Speaker: Shilpa Gajarawala (USA)
Evaluation of Common Sexual Dysfunctions and Treatment Outcome in a Canadian Sexual Medicine Practice (#048)
Speaker: Rawan Gari (Saudi Arabia)
A Double-Blind, Sham Controlled Prospective Pilot Study of Urinary Stress Incontinence and Sexual Function in Women After 6 Treatments with HIFEM Technology (Emsella): Interim Analysis (#049)
Speaker: Irwin Goldstein, MD, IF (USA)
The Effects of Radiofrequency on Female Sexual Health (#050)
Speaker: Troy Hailparn (USA)
Effectiveness of App Based Intervention for the Treatment of Female Sexual Dysfunction (#051)
Speaker: Lyndsey Harper (USA)
Undergraduates' Definitions of Sexual Consent: The Role of Rape Myth Acceptance (#052)
Speaker: Sabira Ahmed (USA)
Proper Assessment for Cosmeto-gynecological Interventions: The Need to Evaluate the Relationship Discord, Body Dysmorphic Syndrome, and the Correct Energy-Based Technology (#053)
Speaker: Michael Krychman (USA)
Topical Alpha-1 Adrenergic Receptor Agonist Applied to the Nipple Areola Complex Significantly Improves Female Orgasmic Function (#054)
Speaker: Michael Krychman (USA)
A New Medical Device to Assist in the Treatment of Collison Dyspareunia: Results from the Soft Launch of Ohnut (#055)
Speaker: Michael Krychman (USA)
The Milli™; the Only Patient Controlled Expanding Dilator: Follow Up Survey Experience (#056)
Speaker: Michael Krychman (USA)
Rethinking the Techno Vagina: A Case Series of Patient Complications Following Vaginal Laser Treatment for Atrophy (#057)
Speaker: Michael Krychman (USA)
Genital Moisturizing Cosmetics: Do Not Forget the Vulva (#058)
Speaker: Michael Krychman (USA)
Speeding Assessment in Couples' Sex Therapy using an Online Self-assessment Tool (#059)
Speaker: Elizabeth Larson (USA)
Sexual Function Differences Among Female Marijuana Users with Sexual Dysfunction (#060)
Speaker: Becky K. Lynn, MD, IF (USA)
Including Sexuality in the Clinic Visit: Report of an Online Survey of a Sexuality Questionnaire in English and Spanish (#061)
Speaker: Lourdes Mantecon-Garza (USA)
ColorDoppler Ultrasound in the Evaluation of the Cardiometabolic Profile in Women With Sexual Dysfunction: A Gender Perspective (#062)
Speaker: Elisa Maseroli, MD (Italy)
Flibanserin: Enhanced Pharmacovigilance Study to Assess and Analyze the Risks of Adverse Events of Special Interest (#063)
Speaker: Leah Millheiser (USA)
Attitude of Women Nurse Practitioners for Embarrassing Female Sexual and Urinary Symptoms in Korea (#064)
Speaker: Kweonsik Min (Korea)
Vulvar Findings in GSM Patients Correlate with Severity of Overactive Bladder (#065)
Speaker: Noriko Ninomiya (Japan)
Pudendal Neuromodulation for Treatment of Female Orgasmic Disorder (#066)
Speaker: Elizabeth Olive (USA)
Number Needed to Harm for Treatments of Female Sexual Dysfunction (#067)
Speaker: Robert Pyke (USA)
Female Sexual Dysfunctions Associated With Male Premature Ejaculation (#068)
Speaker: Robert Pyke (USA)
Hormonal Contraceptive Use and Sexual Functioning among Young Women Who Experienced Sexual Victimization (#069)
Speaker: Anneliis Sartin-Tarm (USA)
Characteristics of Lubricants Sold in Pharmacies and Sex Shops in Capitals of 3 Brazilian States (#070)
Speaker: Ariel Gustavo Scafuri (Brasil)
Estradiol does not Increase with Low-dose Testosterone Replacement in Women after Menopause (#071)
Speaker: Yuki Sekiguchi (Japan)
The Impact of Vaginal Dryness on Quality of Life and Work Productivity (#072)
Speaker: Temitayo Ogundimu (United Kingdom)
Characterization of Female Periurethral Glandular Tissue in the Periurethral Space Negatively Impacted by Mid-Urethral Sling Surgery (#073)
Speaker: Diane Tomalty (Canada)
MATE 2 Survey: Men’s Perspectives Toward Aging and Their Partner’s Menopause (#074)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
Ease of Use of a Contraceptive Vaginal System (CVS), Containing Segesterone Acetate and Ethinyl Estradiol (SA/EE) (#075)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
Growth of the Vulvar Vaginal Atrophy (VVA) Therapy Market (#076)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
Postmenopausal Women Using a Softgel Estradiol Vaginal Insert to Treat Moderate to Severe Dyspareunia Were Satisfied With it and Preferred it Over a Previous Treatment (#077)
Speaker: Becky K. Lynn, MD, IF (USA)
Why Core Emotions Matter: Understanding Subcortical Affective Circuits as Key to Treatment of Sexual Disorders (#078)
Speaker: Nan Wise (USA)
Evaluating the Performance of a Low-cost Mobile Phone Attachable Microscope in Cervical Cytology (#079)
Speaker: Ali Naqvi (USA)
Patient Reported Satisfaction Rating After Attending a Multidisciplinary Psychoeducational Sexual Wellness Program (#080)
Speaker: Mary Lynn (USA)
Practice and Perception of Female Genital Mutilation in Women of Reproductive Age in North East Nigeria (#081)
Speaker: Raphael Attah (Nigeria)
Prevalence of Adenomyosis in Chronic Pelvic Pain Patients Undergoing Hysterectomy (#082)
Speaker: Nita Desai (USA)
The Effect of Ristela Supplementation on Female Sexual Function in Women Taking Antidepressants: An Open Label Trial (#083)
Speaker: Susan Kellogg-Spadt, PhD, CRNP, IF (USA)
Improvements in Female Sexual Function Index (FSFI) Domains Over Time after Flibanserin Treatment in Premenopausal Women with Hypoactive Sexual Desire Disorder (HSDD) (#084)
Speaker: Noel Kim, PhD, IF (USA)
Sunday, March 8, 2020
Morning
07:00 a.m. - 08:00 a.m.
Location: Peninsula 5-7
Meet the Expert Breakfast
Hormone Modulating Treatments for the Treatment of Androgen-mediated Cutaneous Disorders (AMCDs)
Speaker: Andrew Goldstein, MD, IF, FACOG (USA)
PGAD
Speaker: Irwin Goldstein, MD, IF (USA)
Recommending Sexual Devices and Aides: What's Best for Whom?
Speaker: Susan Kellogg-Spadt, PhD, CRNP, IF (USA)
The Vulva - How to See With Your Eyes Open and Identify Sources of Pain
Speaker: Alyse Kelly-Jones, MD, IF, FACOG (USA)
Treating GSM in Breast Cancer Patients
Speaker: Becky K. Lynn, MD, IF (USA)
Consensus Guidelines on the Use of Systemic Testosterone for Sexual Function in Women
Speaker: Sharon Parish, MD, IF, NCMP (USA)
Nonhormonal Treatment of Sexual Dysfunction in Menopausal Women
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
Care of the Transgender Patient in Your Practice
Speaker: Maureen Whelihan, MD, FACOG (USA)
08:00 a.m. - 09:30 a.m.
Location: Peninsula 4
Research Podium Session 4 - Education & Clinical Trials
Moderators: Stanley Althof, PhD, IF (USA) & Kristin Christiansen, MD (USA)
08:00 a.m. - 08:10 a.m.
Can We Give What We Don't Own: Self-objectification's Role in Sexual Consent Behaviors and Attitudes (#031)
Speaker: Allexa Zwinck (USA)
08:10 a.m. - 08:20 a.m.
A Novel Pathway for the Increased Inclusion of Sexual Health Education in Undergraduate Medical Education (#032)
Speaker: Elisabeth Gordon (USA)
08:20 a.m. - 08:30 a.m.
Evidence Not Rhetoric - A Sexual Health Elective Course for Medical Students (#033)
Speaker: Kari Stausmire (USA)
08:30 a.m. - 08:40 a.m.
The Contribution of the Cervix to the Female Sexual Response: Development of a Self-Reported Patient Survey (#034)
Speaker: Olivia Giovannetti (Canada)
08:40 a.m. - 08:50 a.m.
Patient Reported Outcomes of a Robotic-Assisted Double-Skin Flap Vaginoplasty Technique for Transfeminine Genital Reconstructive Surgery (#035)
Speaker: Jessica Schardein (USA)
08:50 a.m. - 09:00 a.m.
Two-Arm, Prospective, Open-Label, Pilot Study of Flibanserin versus Flibanserin and Sex Therapy in Pre- and Postmenopausal Women with HSDD (#036)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
09:00 a.m. - 09:10 a.m.
Open-Label Pilot, Prospective Vulvoscopic Study of Daily Administration of Prasterone Vaginal Inserts in Women with Moderate to Severe Dyspareunia (#037)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
09:10 a.m. - 09:20 a.m.
Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies (#038)
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
09:20 a.m. - 09:30 a.m.
Effects of Sex Steroids on Relaxant/Contractile Pathways in Rat Vagina (#039)
Speaker: Linda Vignozzi, MD (Italy)
08:00 a.m. - 09:30 a.m.
Location: Peninsula 1-3
Instructional Course 4 - Sexual Health in Breast and Gynecologic Cancer Patients
Speakers: Don Dizon, MD (USA) & Mindy Goldman, MD (USA)

Save The Date

ISSWSH Sexual Pain Course 2020
  April 17-18, 2020
CANCELLED DUE TO COVID-19
Read more...

ISSWSH Fall Course 2020
  November 19-21, 2020    176 days left
  DoubleTree Hilton Hotel, Scottsdale, AZ, USA
Read more...

ISSWSH Annual Meeting 2021
  March 4-7, 2021    281 days left
  Renaissance Dallas Hotel, Dallas, TX, USA

Latest Tweets

In observance of Memorial Day, our office will be closed today. Stay well everyone! ISSWSH
Retweet if you plan on tuning in for our webinar this Wednesday, May 27! We can't wait to see you there.… https://t.co/43FnQunHnr ISSWSH
Botox - it's not just for wrinkles anymore. New review article looks at different ways it can alleviate sexual pain… https://t.co/nvgWFGWSR4 ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!